Literature DB >> 8242773

Regulation of plasminogen activator inhibitor-1 levels in human monocytes.

J A Hamilton1, G A Whitty, J Wojta, M Gallichio, K McGrath, G Ianches.   

Abstract

The regulation of PAI-1 synthesis by elutriation-purified human monocytes was studied in vitro and compared to that for PAI-2. PAI-1 formation, as measured by ELISA, was upregulated by TGF-beta (> or = 1 ng/ml) and surprisingly down-regulated by LPS (100 ng/ml), particularly in the presence of TGF-beta; LPS elevated PAI-2 levels (ELISA) while TGF-beta reduced its basal levels and those in LPS-treated cultures. Concomitant changes in mRNA expression occurred. The glucocorticoid dexamethasone (10(-7) M) elevated PAI-1 and acted in concert with TGF-beta in this regard at both the antigen and mRNA levels; interleukin-4 (IL-4) (250 pM) failed to mimic the steroid in its regulation of PAI-1 formation. Since monocyte/macrophage PA activity is likely to be important in tissue remodeling and cell migration at sites of inflammation and in fibrinolysis, it is proposed from these studies that PAI-1, as well as the usually considered PAI-2, may be involved in the negative control of PA activity in this cell type. The synthesis of each PAI appears to be independently regulated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242773     DOI: 10.1006/cimm.1993.1263

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Identification and characterization of differentially expressed cDNAs of the vector mosquito, Anopheles gambiae.

Authors:  G Dimopoulos; A Richman; A della Torre; F C Kafatos; C Louis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

2.  Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.

Authors:  V A Ploplis; I Cornelissen; M J Sandoval-Cooper; L Weeks; F A Noria; F J Castellino
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

3.  Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.

Authors:  A Estellés; S Grancha; J Gilabert; T Thinnes; M Chirivella; F España; J Aznar; D J Loskutoff
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera.

Authors:  K Mészáros; S Aberle; M White; J B Parent
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease.

Authors:  Mei-Yun Tang; Fredric A Gorin; Pamela J Lein
Journal:  Ageing Neurodegener Dis       Date:  2022-01-29

7.  Krüppel-Like Factor 4 Inhibits the Transforming Growth Factor-β1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial Cells.

Authors:  Fang Sun; Ke Hu
Journal:  Dis Markers       Date:  2015-12-29       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.